We are live on
!
Find out more
WMRU
William Marsh Rice University Portfolio holdings
AUM
$219M
1-Year Est. Return
16.08%
This Fund
S&P 500
This Quarter
Est. Return
-3.51%
1 Year Est. Return
+16.08%
3 Year Est. Return
+4.44%
5 Year Est. Return
+49.64%
10 Year Est. Return
–
AUM
$85.8M
AUM Growth
-$3.58M
(-4%)
Cap. Flow
-$392K
Cap. Flow
% of AUM
-0.46%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
–
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Klaviyo
KVYO
|
+$201K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vera Therapeutics
VERA
|
+$593K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 99.71% |
| 2 | Technology | 0.29% |
| 3 | Healthcare | 0% |
Similar funds
ICVCFIA
FA
TCG
AWM
ORP
UAM
FCM
DA
William Marsh Rice University's Q3 2024 Portfolio in Review
As of Q3 2024, William Marsh Rice University held 3 positions worth $85.8M, down 4% from $89.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
William Marsh Rice University's Q3 2024 filing shows 1 new and 1 closed positions. Its largest new stake was Klaviyo: 6,930 shares worth $245K. The largest sale was Vera Therapeutics, an estimated $593K.
By sector, the portfolio is most concentrated in Energy at 100% of assets, up from 99% a quarter earlier, followed by Technology and Healthcare.
- William Marsh Rice University's largest Q3 2024 buy was Klaviyo: 6,930 shares worth $245K.
- William Marsh Rice University fully exited Vera Therapeutics in Q3 2024, selling an estimated $593K.
- William Marsh Rice University's ten largest holdings make up 100% of its $85.8M portfolio in Q3 2024.
- William Marsh Rice University opened 1 new position and closed 1 in Q3 2024.
- William Marsh Rice University's portfolio value fell 4% quarter-over-quarter to $85.8M.
Based on William Marsh Rice University's 13F filing for Q3 2024, filed 16 Oct 2024.